tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rivian Stock (RIVN) Hits a New 52-Week High — Will the Rally Continue in 2026?

Story Highlights

Rivian shares reached a new 52‑week high today as investors grew more confident in its long‑term strategy.

Rivian Stock (RIVN) Hits a New 52-Week High — Will the Rally Continue in 2026?

Rivian (RIVN) stock climbed to a new 52-week high today, signaling renewed confidence in the company’s long-term strategy. The market optimism is driven by its new, in-house developed AI chip and autonomy platform, more affordable R2 SUV launching in 2026, and positive analyst opinions. Importantly, Wedbush analyst Daniel Ives sees the momentum continuing in 2026, calling it a “significant year” for Rivian.

Claim 50% Off TipRanks Premium and Invest with Confidence

The analyst raised his price target on RIVN stock to $25 (11.3% upside potential) from $16, while reiterating a Buy rating.

The move marks a sharp turnaround from earlier in the year, when concerns about cash burn, production issues, and slowing EV demand dragged the stock down. Now, sentiment is improving, and Rivian seems well-poised for a rebound in the EV market.

Analyst Sees Rivian Gaining Momentum

Ives highlighted the upcoming launch of the company’s R2 platform in the first half of 2026. The new model line is expected to expand its customer base and boost delivery volumes, a key milestone as the company works to scale production and strengthen its financial footing.

He added that Rivian is managing costs carefully amid tariff risks and ongoing investments in manufacturing and technology. This should help the company handle near-term challenges while moving toward a more efficient operation.

Is RIVN Stock a Buy or Sell?

Turning to Wall Street, analysts have a Hold consensus rating on RIVN stock based on eight Buys, eight Holds, and five Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average RIVN price target of $16.22 per share implies 27.78% downside risk.

See more RIVN analyst ratings

Disclaimer & DisclosureReport an Issue

1